Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

167
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
167
Isotopes and Radioisotopes01:28

Isotopes and Radioisotopes

8.7K
In the early 1900s, English chemist Frederick Soddy realized that an element could have atoms with different masses that were chemically indistinguishable. These different types are called isotopes — atoms of the same element that differ in mass. Isotopes differ in mass because they have different numbers of neutrons but are chemically identical because they have the same number of protons. Soddy was awarded the Nobel Prize in Chemistry in 1921 for this discovery.
An isotope containing...
8.7K
Positron Emission Tomography01:29

Positron Emission Tomography

4.3K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiopharmaceutical therapy provides superior survival advantage for leptomeningeal metastasis compared to external beam radiotherapy.

Neuro-oncology·2026
Same author

Preclinical Evaluation of Radium-223 and Immune Checkpoint Inhibitors Using an Immune-Competent Model of Prostate Cancer Bone Metastases.

Precision oncology·2026
Same author

Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors.

Radiation (Multidisciplinary Digital Publishing Institute)·2026
Same author

A MET-Targeted Variable New Antigen Receptor (VNAR) Theranostic for Non-Small Cell Lung Cancer.

bioRxiv : the preprint server for biology·2026
Same author

Enhanced Antitumor Efficacy of <sup>225</sup>Ac-NM600 Compared to <sup>177</sup>Lu-NM600 in Prostate Cancer Models.

International journal of radiation oncology, biology, physics·2025
Same author

Quantitative In Vivo Cherenkov Luminescence Imaging and Dosimetry of <sup>86</sup>Y-NM600.

ArXiv·2025

Related Experiment Video

Updated: Jul 26, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.0K

Theranostics and Patient-Specific Dosimetry.

Bryan Bednarz1

  • 1Department of Medical Physics, University of Wisconsin - Madison, Madison, WI.

Seminars in Radiation Oncology
|June 18, 2023
PubMed
Summary
This summary is machine-generated.

Radiopharmaceutical therapy (RPT) offers targeted cancer treatment. Patient-specific dosimetry, aided by new software, enhances RPT efficacy and safety for improved oncology outcomes.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.4K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K

Related Experiment Videos

Last Updated: Jul 26, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.0K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.4K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Medical Physics

Background:

  • Radiopharmaceutical therapy (RPT) delivers targeted radioactive drugs to cancer cells.
  • Theranostics combines RPT with imaging to identify suitable patients and guide treatment.
  • Patient-specific dosimetry quantifies radiation dose to tumors and healthy tissues.

Purpose of the Study:

  • To highlight the benefits of dosimetry in radiopharmaceutical therapy.
  • To emphasize the role of theranostics in personalized cancer medicine.
  • To advocate for the adoption of advanced dosimetry methods in clinical oncology.

Main Methods:

  • Utilizing imaging of RPT drugs or companion diagnostics to assess patient eligibility.
  • Performing patient-specific dosimetry to determine optimal radiation activity.
  • Employing FDA-cleared software for efficient and accurate dosimetry calculations.

Main Results:

  • Clinical data increasingly supports significant benefits from dosimetry in RPT.
  • Advanced software enables more accurate and efficient RPT dosimetry compared to traditional methods.
  • Dosimetry optimizes therapeutic efficacy by determining precise activity levels for patients.

Conclusions:

  • Dosimetry is crucial for maximizing therapeutic efficacy in RPT.
  • Modern dosimetry software facilitates personalized medicine in oncology.
  • Adopting RPT with dosimetry promises improved outcomes for cancer patients.